Research statistics
Hexarelin (Examorelin) research: publications and trials
At a glance
Publications, all years
289
Since 1994
Publications in 2026 so far
4
Through November 15, 2026
Human clinical research
35.2%
100 of 284 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
25
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
53.9%
118 animal · 34 in vitro · 1 computational
Records that only mention it
25
Not counted above
Status in the library: Research only. Groups: Growth hormone axis. 5 publications are not yet classified by study type.
Publications by year
Hexarelin (Examorelin) publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1994 | 4 | 2 | 0 | 0 | 6 |
| 1995 | 13 | 3 | 0 | 0 | 16 |
| 1996 | 9 | 3 | 0 | 0 | 12 |
| 1997 | 18 | 6 | 4 | 0 | 28 |
| 1998 | 15 | 11 | 5 | 0 | 31 |
| 1999 | 15 | 8 | 2 | 4 | 29 |
| 2000 | 8 | 12 | 1 | 0 | 21 |
| 2001 | 5 | 11 | 4 | 0 | 20 |
| 2002 | 5 | 10 | 1 | 1 | 17 |
| 2003 | 2 | 7 | 1 | 0 | 10 |
| 2004 | 3 | 5 | 2 | 0 | 10 |
| 2005 | 0 | 3 | 3 | 0 | 6 |
| 2006 | 1 | 5 | 0 | 0 | 6 |
| 2007 | 1 | 2 | 0 | 0 | 3 |
| 2008 | 0 | 4 | 1 | 1 | 6 |
| 2009 | 0 | 5 | 0 | 0 | 5 |
| 2010 | 0 | 4 | 0 | 0 | 4 |
| 2011 | 0 | 3 | 1 | 0 | 4 |
| 2012 | 0 | 7 | 0 | 0 | 7 |
| 2013 | 0 | 5 | 0 | 0 | 5 |
| 2014 | 0 | 4 | 1 | 0 | 5 |
| 2015 | 1 | 2 | 1 | 0 | 4 |
| 2016 | 0 | 4 | 0 | 0 | 4 |
| 2017 | 0 | 4 | 0 | 0 | 4 |
| 2018 | 0 | 4 | 1 | 0 | 5 |
| 2019 | 0 | 3 | 0 | 0 | 3 |
| 2020 | 0 | 3 | 0 | 0 | 3 |
| 2021 | 0 | 4 | 0 | 1 | 5 |
| 2022 | 0 | 1 | 0 | 0 | 1 |
| 2023 | 0 | 3 | 0 | 0 | 3 |
| 2024 | 0 | 1 | 0 | 0 | 1 |
| 2025 | 0 | 1 | 0 | 0 | 1 |
| 2026 (to date) | 0 | 3 | 1 | 0 | 4 |
Study types
| Animal study | 118 |
|---|---|
| Other clinical trial | 70 |
| In vitro study | 34 |
| Review | 29 |
| Randomized controlled trial | 25 |
| Not yet classified | 5 |
| Observational human study | 4 |
| Editorial, letter or other | 2 |
| Case report | 1 |
| Computational study | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Endocrinology | 137 |
|---|---|
| Cardiovascular | 65 |
| Neurological and mental health | 55 |
| Metabolic health | 40 |
| Obesity and weight management | 27 |
| Longevity and aging | 23 |
| Musculoskeletal | 20 |
| Reproductive and sexual health | 13 |
| Gastrointestinal | 10 |
| Oncology | 10 |
| Immune system | 6 |
| Tissue repair | 3 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
European journal of endocrinology · March 1, 2002 · Randomized controlled trial · cited 6 times
PMID 11888836 · DOI 10.1530/eje.0.1460310 · Human clinical research
- Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
The Journal of clinical endocrinology and metabolism · October 1, 2001 · Randomized controlled trial · cited 720 times · open access
PMID 11600590 · DOI 10.1210/jcem.86.10.8098 · Human clinical research
- Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
The Journal of clinical endocrinology and metabolism · March 1, 2001 · Randomized controlled trial · cited 516 times
PMID 11238504 · DOI 10.1210/jcem.86.3.7314 · Human clinical research
- Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.
Journal of endocrinological investigation · February 1, 2001 · Randomized controlled trial · cited 12 times
PMID 11263473 · DOI 10.1007/bf03343815 · Human clinical research
- Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
Journal of internal medicine · June 1, 2000 · Randomized controlled trial · cited 26 times · open access
PMID 10886488 · DOI 10.1046/j.1365-2796.2000.00676.x · Human clinical research
- The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
The Journal of clinical endocrinology and metabolism · July 1, 1999 · Randomized controlled trial · cited 97 times
PMID 10404825 · DOI 10.1210/jcem.84.7.5811 · Human clinical research
- Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.
Journal of endocrinological investigation · April 1, 1999 · Randomized controlled trial · cited 79 times · open access
PMID 10342360 · DOI 10.1007/bf03343555 · Human clinical research
- Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
Journal of endocrinological investigation · February 1, 1999 · Randomized controlled trial · cited 16 times
PMID 10195374 · DOI 10.1007/bf03350886 · Human clinical research
- Growth hormone secretagogues: mechanism of action and use in aging.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · February 1, 1998 · Randomized controlled trial · cited 19 times
PMID 10990440 · DOI 10.1016/s1096-6374(98)80317-1 · Human clinical research
- Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
Neuroendocrinology · December 1, 1997 · Randomized controlled trial · cited 43 times
PMID 9430449 · DOI 10.1159/000127269 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.
Endocrine reviews · October 1, 1998 · Review · cited 837 times
PMID 9793762 · DOI 10.1210/edrv.19.5.0346 · Reviews and meta-analyses
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
The Journal of cell biology · December 16, 2002 · Animal study · cited 724 times · open access
PMID 12486113 · DOI 10.1083/jcb.200207165 · Animal studies
- Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
The Journal of clinical endocrinology and metabolism · October 1, 2001 · Randomized controlled trial · cited 720 times · open access
PMID 11600590 · DOI 10.1210/jcem.86.10.8098 · Human clinical research
- Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
The Journal of clinical endocrinology and metabolism · March 1, 2001 · Randomized controlled trial · cited 516 times
PMID 11238504 · DOI 10.1210/jcem.86.3.7314 · Human clinical research
- Growth hormone secretagogue binding sites in peripheral human tissues.
The Journal of clinical endocrinology and metabolism · October 1, 2000 · In vitro study · cited 416 times
PMID 11061542 · DOI 10.1210/jcem.85.10.6846 · In vitro studies
Latest publications
- Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice.
Journal of molecular histology · September 18, 2026 · Animal study · cited 0 times
PMID 42758352 · DOI 10.1007/s10735-026-10976-z · Animal studies
- Protective and restorative effects of hexarelin on MPTP-induced lung injury in mice.
Journal of basic and clinical physiology and pharmacology · August 21, 2026 · Animal study · cited 0 times
PMID 42619489 · DOI 10.1515/jbcpp-2026-0178 · Animal studies
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access
PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses
- Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.
Indian journal of pharmacology · March 2, 2026 · Animal study · cited 0 times · open access
PMID 41766237 · DOI 10.4103/ijp.ijp_176_24 · Animal studies
- Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.
Journal of analytical toxicology · July 1, 2025 · In vitro study · cited 1 times
PMID 40465419 · DOI 10.1093/jat/bkaf038 · In vitro studies
- Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.
Frontiers in pharmacology · February 7, 2024 · Animal study · cited 3 times · open access
PMID 38384295 · DOI 10.3389/fphar.2024.1303342 · Animal studies
- Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
Nanoscale · December 7, 2023 · Computational study · cited 20 times · open access
PMID 37982184 · DOI 10.1039/d3nr05571j · Computational studies
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.
European journal of medical research · September 14, 2023 · Animal study · cited 14 times · open access
PMID 37710348 · DOI 10.1186/s40001-023-01318-w · Animal studies
- Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.
International journal of molecular sciences · January 4, 2023 · In vitro study · cited 4 times · open access
PMID 36674509 · DOI 10.3390/ijms24020993 · In vitro studies
- Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models.
Frontiers in physiology · January 21, 2022 · Animal study · cited 2 times · open access
PMID 35126171 · DOI 10.3389/fphys.2021.766818 · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Examorelin; Hexarelin
((TITLE_ABS:"Examorelin" OR CHEM:"Examorelin") OR (TITLE_ABS:"Hexarelin" OR CHEM:"Hexarelin")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Hexarelin (Examorelin) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/hexarelin